2012 Global and China cardiac stent industry depth research report

  • 440 views
Uploaded on

 

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
440
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
3
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. 2012 Global and China cardiac stent industry depth researchreportReport Details:Published:September 2012No. of Pages: 234Price: Single User License – US$6500This report is currently the most professional and the most comprehensive system of the field ofcardiac stents depth market research reports. The report first describes the heart stentbackground knowledge related concepts, including heart stents, classification application industrychain structure, industrial Overview, dynamic analysis, international market and domestic marketdynamics analysis, macroeconomic environment analysis and economic situation in the heartstent industry affect cardiac stent industry of national policy and planning analysis, heart stentproducts, production technology, product cost structure; then detailed statistics of Global andChina major corporate of heart stents capacity production cost selling price profit production valueprofit margin data, at the same time statistics these enterprises cardiac stent products customersapplications producing energy market position in enterprise contact way and other information,then these enterprises related data carried out summary statistics and summary analysis of theglobal and Chinese heart stent production energy market share, production market share, thedemand for supply of supply and demand relationship, Import Export consumption statistics, alsointroduced global and heart stents 2009-2013 annual production capacity production price costprofit production value profit margin, after the analysis of cardiac stent industry upstream rawmaterial downstream customers and products instead of survey analysis, and describes cardiacstents marketing channels, industry trends, and strategy recommendations, and finally the use ofcase mode a the heart stent new project SWOT analysis and investment feasibility analysis.Overall, this is specifically for the world and the depth of the heart stent industry report, researchcenters, with an objective and fair manner depth analyzes the heart stent industry developmenttrend for customers to conduct competitive analysis, development planning, investment decision-making provide support and basis for, the support and help of many heart stents industrial chain,technical personnel and marketing personnel in the course of the operation, to express mygratitude in this together.Get your copy of this report @http://www.reportsnreports.com/reports/195662-2012-global-and-china-cardiac-stent-industry-depth-research-report.html
  • 2. Major points covered in Table of Contents of this report includeTable of ContentsChapter heart stents Industry Overview 11.1 cardiac stents Definition 1The 1.2 the heart stents classification and Application 11.3 heart stent surgery 31.4 heart stent industry chain structure 101.5 cardiac stent industry overview 14Chapter II cardiac stent industry at home and abroad market analysis 212.1 cardiac stents Industry international market analysis 212.1.1 the heart stents international market development course 212.1.2 cardiac stent products and technology developments 222.1.3 cardiac stents competitive landscape analysis 282.1.4 cardiac stents major international national development situation analysis 332.1.5 of heart stents international market trends 372.2 cardiac stents Industry domestic market analysis 432.2.1 the heart stent domestic market development course 43Dynamic 43 2.2.2 cardiac stent products and technologies2.2.3 cardiac stents competitive landscape analysis 472.2.4 cardiac stents major domestic regional development situation analysis 502.2.5 the heart stent domestic market development trend of 532.3 cardiac stent industry domestic and international market comparative analysis of 56Chapter heart stent development environment Analysis 593.1 Chinas macroeconomic environment analysis 593.1.1 Analysis of Chinas GDP 593.1.2 Chinese CPI Analysis 613.2 European economic environment analysis and impact 653.3 U.S. economic environment analysis and impact 683.4 global economic environment analysis and impact 71Chapter heart stent industry, national policy and planning 724.1 National planning policy and development 724.1.1 "Twelve Five" period deepening medical and health system planning 724.1.2 2012 medical device industry will be affected by the policy support 744.1.3 "Twelve Five" period other key health reform 754.1.4 "Healthy China 2020" Strategy Research Report "released 754.2 sub-industry policy analysis 764.2.1 industry authorities and industry regulatory regime 764.2.2 national industrial policy 774.2.3 The main industry regulatory regulations and standards 774.2.4 interventional medical device industry policies and regulations 784.3 local policies and development 78The 4.4 downstream industry policy and demand analysis of 80
  • 3. 4.5 the recent hotspots and the industry impact 81Chapter heart stent technology, process and cost structure 825.1 heart stents 825.2 cardiac stent technology process analysis 875.3 cardiac stents cost structure analysis 89Chapter 2009-2013 heart stent production, supply and demand market status and forecastanalysis 906.1 2009-2013 the heart stent capacity production statistics 90Heart stents yield sales market share analysis 6.2 2009-2013 962009-2013 demand for heart stents 6.3 Summary 1036.4 2009-2013 the heart stents supply demand gap in the amount of 106Cardiac stents Import Export consumption 107 6.5 2009-20136.6 2009-2013 the average cost of cardiac stents, price, production value, profit margins 108Chapter VII of the heart stent core enterprise research 1097.1 Boston Scientific (Boston Scientific) 1097.2 Abbott (Abbott Laboratories) - Guidant Guidant 1197.3 Medtronic (Medtronic) 1247.4 Johnson & Johnson (J & J Cordis) 1297.5 Biosensors (Biosensors International) 1317.6 BIOTRONIK (Biotronik) 1367.7 Industry poly Medical (OrbusNeich) 1427.8 Sorin Group (Sorin Group) 1497.9 Berenger (B.Braun) 1537.10 Bard (C. R. Bard) - ClearStream 1567.11 minimally invasive medical (MicroPort) 00853.HK 1597.12 Dunlop Medical (Lepu) 30003.CH 1677.13 JW Medical Systems (JW) 1747.14 Liaoning biological (Yinyi) 1787.15 Vico medical (Vascore) 1817.16, Shiner Medical (Sinomed) - Fuji Sunshine 1857.17 prone (ESSEN) 1897.18 Jinruikaili 19271900 Rui Feihong 1937.20 Suzhou Huan Morning, Medical Technology Co., Ltd. 194Chapter VIII of the analysis of related industries and 1948.1 upstream raw material prices and the impact on the industry 194The 8.2 upstream Equipment market analysis and the impact on the industry 196The 8.3 downstream demand analysis and impact on the industry 1978.4 substitute products and impact on the industry 198Chapter heart stents marketing channels 2019.1 the heart stents marketing channels Analysis 2019.2 the heart stents marketing channels management 203
  • 4. 9.3 the heart stents marketing channels to establish a strategy 2039.4 of heart stents marketing channels trends 204Chapter heart stent industry trends 206Cardiac stent industry trends 10.1 2012-2016 206Market potential forecast 207 10.2 2012-201610.3 2012-2016 208 technology research and development trends10.4 2012-2016 sales channels and sales trends 208Trends in the development of the competitive landscape in 10.5 2012-2016 209Import and export trends 210 10.6 2012-2016Chapter 11 heart stent industry development proposals 21111.1 Macroeconomic Development Strategies 21111.2 new enterprises to enter the market strategy 214The 11.3 new investment recommendations 21711.4 marketing channel strategy recommendations 21911.5 competitive environment policy recommendations 220Chapter 12 heart stents new project investment feasibility analysis of 22112.1 heart stent project SWOT analysis 22112.2 new heart stent project feasibility analysis 221Chapter XIII cardiac stent industry research concluded 222List of Tables & FiguresFigure heart stents physical mapTable cardiac stents category listFigure heart stent applicationsFigure heart stents ScopeFigure 4 Figure coronary intervention (cardiac stenting) surgical procedureFigure heart stent surgery diagram 5Figure angiography Diagram 5Figure cardiovascular view 6Figure artery catheter WaysFigure cardiovascular stenosis and X-ray imaging 7Figure balloon into the stenosis and balloon dilation 7Figure holder to enter and release processFigure contrast agent imaging confirmed coronary treatment effectFigure heart stent surgery before and afterFigure puncture site local processing, the end of surgery 9Figure 10 Figure coronary intervention (PCI) is mainly used equipmentFigure medical device industry classification 11Table medical equipment industry segments and Instrument Description 11Figure interventional medical devices Type 12Figure medical devices industry products 13Figure heart stent sales chain and the distribution of benefits Mode 13Figure 14 Figure cardiac stent industry chain structure
  • 5. Figure heart stent study technology trends 24Figure study the course of development of drug-eluting stents 25Figure 2011 United States and Europe and other regions in the world in the heart stentsproduction market share Figure 282009-2015 global drug eluting stents total stent market share of 29Figure 2011 Global and U.S. drug-eluting stent market share of 30Table of foreign brands and characteristics of the coronary stent represents a list of 30Table coronary stent market competition evolution history 31Figure 2009 global cardiac stent manufacturers market share distribution of 31Table 79 global coronary stent manufacturers List 31Figure global output value of the medical equipment market share in China, the U.S., Japan andEurope 382010-2016 global coronary stent system sales revenue market size ($ millions) 39Table the size of the global medical device market in 2009-2016 (100 million U.S. dollars) andinterventional medical device market size (million dollars) and accounted for 392009-2016 the size of the global medical device market (100 million U.S. dollars) andinterventional medical device market size (million dollars) and its growth rate of 40Global stent market size (100 million dollars) in 2009-2016, the heart stent market size (milliondollars) and cardiovascular interventional device market size (100 million U.S. dollars) andaccounted for 40Figure 2009-2016 Global System for cardiac stents market size (million dollars) andcardiovascular interventional device market size (U.S. $ billion) and growth rate 41Global stent market size (million dollars) in 2009-2016 and heart stents market size (U.S. $ billion)and growth rate 412009 Global Cardiovascular interventional treatment equipment products classified sales (100million U.S. dollars) 42Figure global cardiovascular disease interventional therapy device products output value marketshare distribution 42Figure the first generation arterial stents - bare metal stents (BMS) 44Figure second-generation arterial stents - drug-eluting stents (DES) 45The third generation artery stenting Figure - soluble bracket 45Figure medical equipment sales revenue of Shanghai, Beijing and Shandong, Guangdong,Jiangsu and other regions nationwide proportion of 51Figure medical equipment regional distribution of production capacity and a representativeenterprise 51A list of 52 of the table in Shanghai, China, Beijing, Guangzhou, Shenzhen, Qingdao, Hunan,Inner Mongolia and other provinces stent reimbursementFigure domestic health insurance type share distribution of 52Figure 2000-2012 China PCI surgical cases (million cases) 532007-2014 Chinese coronary stent market size (million) 542008-2015 the PCI surgery (000 cases) and cardiac stents market size ($ billion) 542008-2010 cardiac stent market drug-eluting stents and bare metal stents market share of more
  • 6. than 552009 Chinese the heart stents production enterprise market share distribution (by hospital terminalsales) 552009 Chinese the heart stents production enterprise market share distribution (hospital terminalsales) 56Table Sino-US similar stent price comparison table 56Table Sino-US of heart stents producer and Features contrast 57Table overseas and major types of drug-eluting stents 58Figure 2006-2015 China medical equipment output value ($ billion) and growth rate 59Figure 20001-2011 GDP (billion) and growth rate 60Figure 2007-2011 China medical equipment market size (billion) share of GDP 601980-2030 Chinas urban population size (million) forecast 61Table 2006-2011 China GDP (billion) and growth rate 61Figure 2007-2011 China cardiovascular stent market size ($ bn) and growth rate 622007-2015 personal medical expenses ($) 622007 to 2015, Chinas per capita health care spending and the national health expenditures(billion) 63Figure 2011-2016 Chinas rate of population growth and aging conditions 642000-2011 (cases) and the growth rate of Chinese medical market, the number of PCI operation64Figure European prices and gross national product (GDP) declining trend 66Figure European PMI trend 66The U.S. core CPI and PCE growth rate comparison 69Changes in the U.S. private savings rate (left) and changes in U.S. net exports / GDP ratio (right)70The proportion of the U.S. public debt and budget deficit to GDP; 70Table "during the 12th Five-deepening medical and health system planning cum embodiment 72Table of the worlds drug-eluting stent major R & D and product manufacturers (as of 2011) 82Figure coronary drug-eluting stents process flow diagram 86Figure drug-eluting stent structure Figure 87Figure coronary drug-eluting stent system diagram 87Production flow chart of Figure bare stent 88Figure 89 Figure stent system production process2012 heart stent cost structure ($ / month) 90Table 16 companies around the world in 2009-2013 the production capacity and the total capacityof the heart stent (ten thousand) List of 90List 91 Table 2009-2013 16 companies worldwide market share of the production capacity ofcardiac stentsTable 16 companies around the world in 2009-2013 of heart stents production and total production(ten thousand) List of 91Table 2009-2013 16 companies around the world the heart stent yield market share List 92The 2009-2013 global cardiac stents capacity production (million) and growth rate 93
  • 7. Table 2009-2013 the global cardiac stents capacity utilization list of 93Table 6 companies in China in 2009-2013 cardiac stents capacity and the total capacity (tenthousand) List 94List 94 Table 2009-2013 China 6 enterprise market share of the production capacity of cardiacstentsTable 6 companies in China in 2009-2013 of heart stents production and total output (tenthousand) List of 94Table 6 companies in China in 2009-2013 the heart stent yield market share List 94Figure 2009-2013 China heart stents capacity production (million) and growth rate 95Table 2009-2013 China heart stent capacity utilization in the list of 95Figure 16 companies in 2011 the heart stent yield market share Figure 96Figure 16 companies around the world in 2012 the heart stent yield market share Figure 972011 heart stents yield of 6 companies in China market share Figure 97Figure 6 companies in China in 2012, the heart stents production market share Figure 98Table 2009-2013 heart stent market mainstream enterprise sales (million) List of 982009-2013 Table cardiac stent market mainstream business sales market share List 99Figure 2011 heart stent market mainstream enterprise sales market share Figure 99Heart stent market mainstream enterprise sales market share in 2012 Figure 1002011 Global cardiac stent market drug-eluting stents and bare metal stents market share of morethan 100The 2011 cardiac stent market drug-eluting stents and bare metal stents market share more than101Table 2009-2013 global stent market size (100 million U.S. dollars), the heart stent market size(100 million U.S. dollars) and accounted for 1012009-2013 global cardiac stent market size (100 million dollars), cardiovascular interventionaldevice market size (100 million U.S. dollars) and accounted for 1012009-2013 global stent market size (100 million dollars), the heart stent market size (U.S. $ billion)and growth rate 102The size of the global heart stent market 2009-2013 (billion U.S. dollars), cardiovascularinterventional device market size (U.S. $ billion) and growth rate 102Table our survey residents incidence of chronic diseases (‰) 103Table coronary heart disease mortality statistics for urban and rural areas in 2008, respectively(1/10 000) 103Table Comparison of coronary heart disease mortality in China and the World 104Table 2009-2013 the global cardiac stents Price (U.S. $ / month), quantity (million) and the outputvalue (100 million U.S. dollars) 104Table 2009-2013 the heart stent Price (U.S. $ / month), quantity (million) and the output value (100million U.S. dollars) 104List 104 Table 2009-2013 Global and China cardiac stent market sales (million)2009-2013 global the PCI surgery Quantity (000 cases), the number of heart stents (million) andgrowth rate 1052009-2013 the number of PCI operation, the use of cardiac stents Number (10,000) and growth
  • 8. rate of 105Table 2009-2013 the global cardiac stents supply demand gap amount (ten thousand) List 106Table 2009 Chinas demand for heart stents distribution 106Table 2009-2013 the heart stents supply the output gap (ten thousand) List 107Table 2009-2013 the heart stents supply demand gap (ten thousand) List 107List 107 Table 2009-2013 China the heart stents production imports export amount ofconsumption (million)Table 2009-2013 the global cardiac stents production (million) (U.S. $ / month) value (million) pricecost profit margin List 108Table 2009-2013 China heart stent production (million) (U.S. $ / month) value (million) price costprofit margin list of 108Table Boston Scientific (Boston Scientific) List of company information (main products, productapplications, origin, production capacity, expansion plans, market position, contact information 13)109Figure Boston Scientific (Boston Scientific) involved in the field of medical devices 113Figure Boston the scientific VeriFLEX ®, Bare-Metal Coronary Stent System (metal bracket) 114Figure Boston Scientific Drug-Eluting Stents (drug-eluting stents) 115Figure ION ™ Paclitaxel-Eluting Platinum Chromium Coronary Stent the System 115Figure Boston Scientific TAXUS ® Express ² ® Coronary Stent System 117Table 2009-2013 cost price of Boston Scientific cardiac stent (Boston Scientific) Production(million) profit margin ($ / a) (million U.S. dollars) in output value information List of 118The 2009-2013 Boston Scientific (Boston Scientific) cardiac stents capacity production (million)and growth rate 118Table Abbott (Abbott Laboratories) List of company information (main products, productapplications, origin, production capacity, expansion plans, market position, and contact information13) 119Tuya Pei MULTI-LINK 8 LL Coronary Stent System 120The Tu Yapei XIENCE Everolimus Eluting Coronary Stent System 120Figure Abbott MULTI-LINK VISION Coronary Stent System 122Table Abbott (Abbott Laboratories) 2009-2013 the heart stents production (million) cost price profit(U.S. $ / a) (million U.S. dollars) in output value profit margins Information List of 1232009-2013 Abbott (Abbott Laboratories) of heart stents capacity production (million) and growthrate 124Table Medtronic (Medtronic) List of company information (main products, product applications,origin, production capacity, expansion plans, market position, contact information 13) 125Figure Medtronic (Medtronic) medical equipment brand 126Figure Medtronic (Medtronic) sales in China heart stent the Integrity products list 127Table 2009-2013 Medtronic cardiac stent (Medtronic) production (million) cost price profit (U.S. $ /month) output value (million) profit margins List 1282009-2013 Medtronic (Medtronic) of heart stents capacity production (million) and growth rate 128Table of Johnson & Johnson (J & J Cordis) List of company information (main products, productapplications, origin, production capacity, expansion plans, market position, contact information 13)
  • 9. 129Table 2009-2013 Johnson & Johnson (J & J Cordis) the heart stent production (million) cost priceprofit (U.S. $ / a) (million U.S. dollars) in output value profit margins List 1302009-2013 Johnson & Johnson (J & J Cordis) cardiac stents capacity production (million) andgrowth rate 130Table Biosensors (Biosensors International) List of company information (main products, productapplications, origin, production capacity, expansion plans, market position, contact information 13)131The heart stents Figure Baisheng Sheng production 133Figure Baisheng Sheng production of cardiac stents Name Glance 134Information List 134 Table 2009-2013 Biosensors (Biosensors International) heart stent production(million) cost price ($ /) output value (million) profit marginFigure 2009-2013 Biosensors (Biosensors International) of heart stents capacity production(million) and growth rate 135Table BIOTRONIK (Biotronik) List of company information (main products, product applications,origin, production capacity, expansion plans, market position, contact information 13) 136Figure BIOTRONIK coronary stent intervention system Lekton Motion 138Figure BIOTRONIK DREAMS - Drug Eluting Absorbable Metal Scaffold 139Figure BIOTRONIK DREAMS is based on proprietary magnesium technology 140Figure BIOTRONIK DREAMS - Key Features 140Figure BIOTRONIK Degradation process for DREAMS 141Information List 141 Table 2009-2013 BIOTRONIK cardiac stent (Biotronik) (million) productioncost price ($ /) output value (million) profit margin2009-2013 BIOTRONIK cardiac stents (Biotronik) capacity production (million) and growth rate142Table American industry poly Medical Devices (Shenzhen) Co., Ltd. List of company information(main products, product applications, origin, production capacity, expansion plans, marketposition, contact information 13) 142Figure Industry poly medical device company Global distribution of 145Figure Industry poly medical device company production of heart stents 146Figure Industry poly medical CONSTANT ™ Coronary Stent 146Watch Industry poly Medical the CONSTANT ™ Coronary Stent Order Information 147Figure Industry poly medical R stent Evolution ™ 2 Coronary Stent System 147Table 2009-2013 Yeju medical cardiac stents (million) production cost selling price profit (U.S. $ /month) output value (million) profit margins Information List of 1482009-2013 industry poly medical cardiac stent production price cost profit production value profitmargin information List of 149Table Sorin Group (Sorin Group) List of company information (main products, productapplications, origin, production capacity, expansion plans, market position, and contact information13) 149Tu Suolin Group (Sorin Group) market share maps 151Table 2009-2013 Sorin Group (Sorin Group) heart stent production (million) cost price profit (U.S.
  • 10. $ / month) output value (million) Margin Information List 1522009-2013 Sorin Group (Sorin Group) production capacity of cardiac stents production (million)and growth rate 152Table B. Braun (B.Braun) List of company information (main products, product applications, origin,production capacity, expansion plans, market position, contact information 13) 153Table B. Braun (B.Braun) Coroflex and Blue coronary stent products Specifications List 154Germany B. Braun the heart stents production (million) in 2009-2013 cost price (/ a) (million U.S.dollars) in output value profit margin information List of 155Germany 2009-2013 Berenger heart stent capacity production (million) and growth rate 155Table Bard (CR Bard) List of company information (main products, product applications, origin,production capacity, expansion plans, market position, and contact information 13) 156Table 2009-2013 Bard (CR Bard) heart stent production (million) cost price profit ($ / a) (millionU.S. dollars) in output value profit margins List 1582009-2013 Bard (CR Bard) of heart stents capacity production (million) and growth rate 159Table List of minimally invasive medical devices (Shanghai) Co., Ltd. (main products, productapplications, origin, production capacity, expansion plans, market position, contact information 13)159Figure minimally invasive medical Mustang coronary stent (bare metal stents) 161Figure minimally invasive medical coronary sirolimus-eluting stent system Firebird 162Figure minimally invasive medical coronary rapamycin-eluting cobalt-based alloy stent systemFirebird2 164Table minimally invasive medical heart Firebird2 compliance table 164Table minimally invasive medical cardiac stents Firebird2 diameter (mm), length (mm) list of 165Table 2009-2013 minimally invasive medical bare metal heart stents production (million) cost priceprofit (U.S. $ / month) output value (million) profit margins List 165Table 2009-2013 minimally invasive medical drug the heart stents production (million) cost priceprofit (U.S. $ / month) output value (million) profit margins Information List of 165Table 2009-2013 minimally invasive medical the heart stents production (million) cost price profit(U.S. $ / a) (million U.S. dollars) in output value profit margins List 1652009-2013 minimally invasive medical cardiac stents capacity production (million) and growth rate166Medical devices, table Lepu (Beijing) Co., Ltd. Company Information List (main products, productapplications, origin, production capacity, expansion plans, market position, contact information 13)167Table Lepu Medical Biguard ™ rapamycin drug-eluting Branch Stent System 168Figure Lepu medical Partner ® intravascular drug eluting stent system (rapamycin) 169Figure Lepu medical Nano Plus ™ vascular carrier containing drugs (rapamycin)-eluting stentsystem 170Table the Lok general medical GuReater ™ cobalt-based alloy Jinlei Pa neomycin drug-elutingstent system (upcoming) 171Table Lepu medical the heart stents production (million) in 2009-2013 cost price profit ($ / a)(million U.S. dollars) in output value profit margins List 172
  • 11. Figure Lepu Medical cardiac stents (ten thousand) 2009-2013 capacity production (million) andgrowth rate 173Table JW Medical Products Co., Ltd. List of (main products, product applications, origin,production capacity, expansion plans, market position, contact information 13) 174Drug-eluting stent 175 the the Tu Jiwei medical Aikesaier (EXCEL)Tu Jiwei medical Aikesaier drug-eluting stents (EXCEL) Order Information 176Table 2009-2013 JW Medical the heart stents production (million) cost price profit (U.S. $ / month)output value (million) profit margins List 1762009-2013 JW Medical cardiac stents capacity production (million) and growth rate 177Table Liaoning Journal of Biomedical Materials R & D Center Co., Ltd. List of company information(main products, product applications, origin, production capacity, expansion plans, marketposition, contact information 13) 178Figure Liaoning biological drug-eluting coronary metallic stent system (Dalian Yinyi vectorcontaining drug (paclitaxel)-eluting stent system) 180Order Information 180 Table the Liaoning biological drug-eluting coronary metallic stent systemLiaoning biological heart stent production (million) in 2009-2013 cost price (/ a) (million U.S.dollars) in output value profit margin information List of 1812009-2013 Liaoning the biological heart stent capacity production (million) and growth rate 181Table Vico Medical Devices (Suzhou) Co., Ltd. List of company information (main products,product applications, place of origin, capacity expansion plans, market position, contactinformation, etc. 13) 182Figure the Vico medical coronary stent system 182Tu Weike Medical Polymer-Free stent (Research Products) 183Table 2009-2013 Vico Medical Devices (Suzhou) Co., Ltd. (ten thousand) heart stent productioncost selling price profit margin information list 184 (/ a) (million U.S. dollars) in output value2009-2013 Vico medical equipment (Suzhou) Co., Ltd. of heart stents capacity production (million)and growth rate 184Table Shiner Medical Science and Technology Co., Ltd. company information list (main products,product applications, origin, production capacity, expansion plans, market position, contactinformation 13) 185Figure Shiner Medical Science and Technology Co., Ltd. of drug-eluting stents BuMATM 186Table Shiner the medical BuMATM bracket information table 187Table Shiner the medical BuMATM bracket Specifications Table 188Table Shiner the medical BuMATM conveyor system compliance table 188Table 2009-2013 Shiner medical heart stent production (million) cost price profit (U.S. $ / month)output value (million) profit margins Information List of 1882009-2013 Shiner medical cardiac stent production capacity production (million) and growth rate189Table prone Technology (Beijing) Co., Ltd. List of company information (main products, productapplications, place of origin, capacity expansion plans, market position, contact information, etc.13) 189Figure prone Ericsson (Tivoli) drug-eluting coronary stent 191
  • 12. Table stent production availability of raw materials table 195Equipment used in the production line of the table bracket and quantity 196Table 198 three clinical classification and treatment of coronary heart diseaseTable of domestic and international marketing of medical devices contrast 205Table PowerStent drug release cardiac stents Chinese industrial process arrangements 218SWOT analysis 218 Figure new project2012 new heart stent Project SWOT analysis of the list of 221Table cardiac stents New Construction Content List 221Table cardiac stents new project ROI and feasibility analysis of 222Contact: sales@reportsandreports.com for more information.